T. Rowe Price Investment Management
THC icon

T. Rowe Price Investment Management’s Tenet Healthcare THC Stock Holding History

T. Rowe Price Investment Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149M Buy
793,887
+605,364
+321% +$111M 0.1% 217
2026
Q1 		$35.6M Buy
188,523
+88,445
+88% +$18.6M 0.02% 398
2025
Q4 		$19.9M Sell
100,078
-2,633
-3% -$532K 0.01% 496
2025
Q3 		$20.9M Buy
102,711
+79,411
+341% +$14.1M 0.01% 495
2025
Q2 		$4.1M Buy
+23,300
New +$3.51M ﹤0.01% 583

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

T. Rowe Price Investment Management's THC Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Tenet Healthcare (THC) stake by 321% in Q2 2026, buying an estimated $111M and bringing the position to 793,887 shares worth $149M. The position accounts for 0.1% of the portfolio, ranked #217.

T. Rowe Price Investment Management first reported a position in THC in Q2 2025 and has held it in 5 quarters since. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • T. Rowe Price Investment Management held 793,887 shares of Tenet Healthcare worth $149M as of Q2 2026.
  • T. Rowe Price Investment Management bought 605,364 Tenet Healthcare shares in Q2 2026, an estimated $111M.
  • Tenet Healthcare made up 0.1% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #217 holding.
  • T. Rowe Price Investment Management first reported a position in Tenet Healthcare in Q2 2025 and has held it in 5 quarters since.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.